A placebo-controlled, double-blind, randomized, parallel study of the withdrawal effects of chronic daily and as-needed dosing with dapoxetine in the treatment of premature ejaculation

Trial Profile

A placebo-controlled, double-blind, randomized, parallel study of the withdrawal effects of chronic daily and as-needed dosing with dapoxetine in the treatment of premature ejaculation

Completed
Phase of Trial: Phase III

Latest Information Update: 15 Nov 2010

At a glance

  • Drugs Dapoxetine (Primary)
  • Indications Premature ejaculation
  • Focus Adverse reactions; Pharmacodynamics; Registrational; Therapeutic Use
  • Sponsors Janssen Research & Development
  • Most Recent Events

    • 01 Mar 2009 Patient-reported outcome results published in BJU International 103: 651-658, No. 5, Mar 2009
    • 11 Jun 2007 Results of a secondary endpoint analysis have been reported.
    • 26 Nov 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top